(Q36474506)

14 August 2017

Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis (English)

1 reference

Elisabeth Steinhagen-Thiessen

14 August 2017

1 reference

3

object named as

Elisabeth Steinhagen-Thiessen

1 reference

14 August 2017

2

Axel Dignass

1 reference

14 August 2017

Wolfgang Kruis

1

1 reference

14 August 2017

Julia Morgenstern

4

1 reference

14 August 2017

Joachim Mössner

5

1 reference

14 August 2017

Stephan Schreiber

6

1 reference

14 August 2017

Maurizio Vecchi

7

1 reference

14 August 2017

Alberto Malesci

8

1 reference

14 August 2017

Max Reinshagen

9

1 reference

14 August 2017

Robert Löfberg

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

44

1 reference

14 August 2017

7001-7006

1 reference

Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Neutrophils, nitrogen oxides, and inflammatory bowel disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Oxidative stress during leukocyte absorption apheresis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717044

21 September 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I44.7001

Vulnerability of intestinal interstitial fluid to oxidant stress

21 January 2018

1 reference

12 December 2020

A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Intensive intravenous treatment of ulcerative colitis

1 reference

12 December 2020

Granulocytapheresis in the treatment of patients with rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I44.7001

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16437606

1 reference